Showing results (51-60 of 144) with videos related to
Sort By:
Pageof 15
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 7, 2014
A novel murine T-cell receptor targeting NY-ESO-1Shannon F Rosati, Maria R Parkhurst, Young Hong, et al.Science Signaling|February 14, 2019
An immunoproteomic approach to characterize the CAR interactome and signalosomeMaria C Ramello, Ismahène Benzaïd, Brent M Kuenzi, et al.Leukemia Research|August 5, 2009
Susceptibility of mantle cell lymphomas to reovirus oncolysisTommy Alain, Huong Muzik, Shannon Otsuka, et al.Cancer Research|October 23, 2014
Cellular factors promoting resistance to effective treatment of glioma with oncolytic myxoma virusFranz J Zemp, Brienne A McKenzie, Xueqing Lun, et al.Molecular Cancer Research : MCR|March 26, 2003
Elevated membrane-type matrix metalloproteinases in gliomas revealed by profiling proteases and inhibitors in human cancer cellsRobert K Nuttall, Caroline J Pennington, Jennifer Taplin, et al.Journal for Immunotherapy of Cancer|April 8, 2025
CD40L stimulates tumor-infiltrating B-cells and improves ex vivo TIL expansionRenata Ariza Marques Rossetti, Leticia Tordesillas, Matthew S Beatty, et al.Cancer Control : Journal of the Moffitt Cancer Center|October 1, 2013
Novel treatments for melanoma brain metastasesRajappa S Kenchappa, Nam Tran, Nikhil G Rao, et al.Clinical Neurology and Neurosurgery|April 7, 2017
Clinical outcomes from maximum-safe resection of primary and metastatic brain tumors using awake craniotomyAnastasia Groshev, Devang Padalia, Sephalie Patel, et al.Science Advances|May 3, 2023
γδ-Enriched CAR-T cell therapy for bone metastatic castrate-resistant prostate cancerJeremy S Frieling, Leticia Tordesillas, Xiomar E Bustos, et al.Investigational New Drugs|August 14, 2012
REO-001: A phase I trial of percutaneous intralesional administration of reovirus type 3 dearing (Reolysin®) in patients with advanced solid tumorsDon G Morris, Xiaolan Feng, Lisa M DiFrancesco, et al.Pageof 15